| II-mGluR | group II metabotropic glutamate receptors |
| III-mGluR | group III metabotropic glutamate receptors |
| 5-HT | serotonin |
| 5-HT2AR | serotonin receptor type 2A |
| 5-HT7R | serotonin receptor type 7 |
| ACTH | adrenocorticotropic hormone |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| AMPAR | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/glutamate receptor |
| BDNF | brain-derived neurotrophic factor |
| DRN | dorsal raphe nucleus |
| Erk | extracellular Signal-regulated Kinase |
| EMA | the European Medicines Agency |
| FDA | the Food and Drug Administration |
| fMRI | functional magnetic resonance imaging |
| GABA | γ-aminobutyrate |
| LC | locus coeruleus |
| MDTN | mediodorsal thalamic nucleus |
| MK801 | dizocilpine |
| mTOR | mammalian target of rapamycin |
| NMDAR | N-methyl-D-aspartate/glutamate receptor |
| OFC | orbitofrontal cortex |
| PPI | prepulse inhibition |
| RTN | reticular thalamic nucleus |
| SNRI | serotonin norepinephrine reuptake inhibitor |
| SSRI | selective serotonin reuptake inhibitor |
| VTA | ventral tegmental area |